Follow
Joo-Young Byun
Title
Cited by
Cited by
Year
A systematic review of economic evaluations of active tuberculosis treatments
JY Byun, HL Kim, EK Lee, SH Kwon
Frontiers in Pharmacology 12, 736986, 2021
102021
Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data
YB Shim, JY Byun, JY Lee, EK Lee, MH Park
Plos one 17 (9), e0274876, 2022
22022
A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC)
JY Byun, SK Park, BP Ng, YS Liu, CR Kim, C Park
Expert Opinion on Pharmacotherapy 23 (11), 1247-1257, 2022
22022
Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer
JY Byun, S Han, A Qdaisat, C Park
Expert Opinion on Drug Safety, 1-9, 2023
12023
Association between epidermal growth factor receptor–tyrosine kinase inhibitors and venous thromboembolism among older patients with advanced non–small cell lung cancer
JY Byun, A Aiyeolemi, A Qdaisat, C Park
Cancer, 2024
2024
The Use of International Nonproprietary Name (INN) and the Factors Affecting the Use of INN in South Korea
J Baek, JY Byun, J Lee, Y Kim, MH Park, EK Lee
Spring International Convention of The Pharmaceutical Society of Korea, 2024
2024
EE261 Economic Burden of Hemophilic Arthropathy in Patients with Hemophilia
JY Byun, JH Jung, MH Park, EK Lee
Value in Health 26 (12), S101, 2023
2023
CO163 Associations between Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIS) and Venous Thromboembolism Among Older Patients with Advanced Non-Small Cell …
JY Byun, AA Aiyeolemi, C Park
Value in Health 26 (6), S45, 2023
2023
Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea
JY Byun, JE Lee, YB Shim, J Kim, SY Lee, BR Shin, NR Yoon, MH Park, ...
Advances in Therapy 40 (2), 550-567, 2023
2023
동맥류성 지주막하출혈 환자의 발병 후 시점별 건강상태에 따른 의료 비용
류민주, 변주영, 백지민, 박미혜, 이의경
2023 한국보건사회약료경영학회 후기 학술대회, 2023
2023
Lifetime cost of Hemophilia B using Health Insurance Review & Assessment Service's Disease subclassifications Statistics of South Korea
JH Jung, JY Byun, J Lim, J Lee, SC Jang, MH Park, EK Lee
Fall International Convention of The Pharmaceutical Society of Korea, 2023
2023
Healthcare cost in patients with hemophilia B
JY Byun, JH Jung, MH Park, EK Lee
Korean Academy of Social & Managed Care Pharmacy, 2023
2023
Economic evaluations of active tuberculosis treatment: Systematic review
JY Byun, EK Lee, HL Kim, SH Kwon
Spring International Conference of The Pharmaceutical Society of Korea, 2021
2021
Economic impact of brain metastasis in patients with non-small cell lung cancer
YB Shim, JY Byun, EK Lee, MH Park
Spring International Conference of The Pharmaceutical Society of Korea, 2021
2021
Healthcare cost and utilization in stage IB-IIIA non-small cell lung cancer patients with or without recurrence using nationwide claims data: retrospective cohort study
JY Byun, JE Lee, YB Shim, MH Park, EK Lee
Fall International Convention of The Pharmaceutical Society of Korea, 2021
2021
PCN96 Economic Burden of BRAIN Metastasis in NON SMALL CELL LUNG Cancer in South Korea: Nationwide Retrospective Cohort Study
YB Shim, JY Byun, P Mi-Hai
Value in Health 23, S439, 2020
2020
Utility weights of health states related to chronic hepatitis B from cost-effectiveness studies: a systematic review and network meta-analysis
JY Byun, SH Kwon, HL Kim
Fall International Convention of The Pharmaceutical Society of Korea, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–17